Cupid Ltd has raised its FY27 revenue guidance to over ₹800 crore and projected a net profit exceeding ₹250 crore. The company expects Q2 FY27 revenue to surpass ₹200 crore, driven by domestic and international market expansion. Key developments include a new asset-light manufacturing venture in South Africa, a USD 5 million follow-on investment from GII Healthcare, and the conversion of 30 lakh warrants in Baazar Style Retail. Recently added to the BSE Group A and Nifty Small Cap 250 indices, the company is scaling its FMCG portfolio and distribution channels.
Cupid Ltd Announces FY27 Revenue Guidance of ₹800+ Crore
Revenue guidance is set at ₹800+ Crore, with net profit guidance projected at ₹250+ Crore for FY27.
Reader Takeaway: Strong operational momentum and global expansion plans drive upward earnings revisions, though execution remains the primary variable.
What just happened
Cupid Limited has released a strong financial roadmap for FY27, signaling aggressive expansion. The management expects Q2 FY27 revenue to cross the ₹200 crore mark. The company has secured a USD 5 million follow-on investment from GII Healthcare and received approval for an asset-light manufacturing venture in South Africa. Additionally, the firm is exercising the conversion of 30 lakh warrants of Baazar Style Retail at ₹328.25 per share.
Why this matters
The revised guidance indicates management confidence in demand for their expanded FMCG product line and core business segments. The South African venture is a strategic move to tap into local demand, potentially bypassing trade barriers and improving margins. The inclusion in major indices like the NIFTY Small Cap 250 and FTSE Emerging Markets All Cap Index enhances institutional visibility and trading liquidity.
Operational Priorities
The company is focused on operationalizing its Palava manufacturing facility to meet rising demand. Simultaneously, they are aggressively deepening their distribution footprint across Indian pharmacy chains, general trade, and modern retail formats to sustain revenue growth.
Risks to watch
While the guidance is optimistic, investors should monitor the successful commissioning of the Palava facility and the integration of international manufacturing ventures. Currency fluctuations in the African markets and competitive pressure in the Indian FMCG space remain relevant factors.
What to track next
Watch for the actual Q2 FY27 performance report to confirm if revenue growth maintains the projected trajectory. The progress of the asset-light venture in South Africa will be a key indicator of long-term international scaling success.